Table 1.

Experimental design for rats in this study

Purpose	Treatment	Number of rats
Pharmacological safety	Vehicle	4
	Ax-C-8 (5 mg/day)	4
	Ax-C-8 (25 mg/day)	4
	Ax-C-8 (49 mg/day)	9
Antioxidant property against acute renal oxidative injury in basal diet (Ax-C-8; 0.02%, w/w)	Vehicle	4
	Vehicle + Fe-NTA 1 h	5
	Ax-C-8 + Fe-NTA 1 h	5
	Vehicle + Fe-NTA 4 h	5
	Ax-C-8 + Fe-NTA 4 h	6
	Vehicle + Fe-NTA 24 h	6
	Ax-C-8 + Fe-NTA 24 h	6
Antioxidant property against subacute renal oxidative injury in Vitamin E-deficient diet	Vehicle	4
	Vehicle + Fe-NTA	6
	Ax-C-8 (0.01%) + Fe-NTA	6
	Ax-C-8 (0.02%) + Fe-NTA	6
	Ax-C-8 (0.04%) + Fe-NTA	6